Oncogene amplification in male breast cancer: analysis by multiplex ligation-dependent probe amplification

Gene Copy Number Variation in Male Breast Cancer by aCGH

(2015) Stefania Tommasi et al.   Analytical Cellular Pathology

Arginine and Glutamate-rich 1 (ARGLU1) Interacts with Mediator Subunit 1 (MED1) and Is Required for Estrogen Receptor-mediated Gene Transcription and Breast Cancer Cell Growth

(2011) Dingxiao Zhang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Frequent promoter hypermethylation of BRCA2, CDH13, MSH6, PAX5, PAX6 and WT1 in ductal carcinoma in situ and invasive breast cancer

(2011) Cathy B Moelans et al.   JOURNAL OF PATHOLOGY

Re: How Do You Tell Whether a Breast Cancer is HER2 Positive? Ongoing Studies Keep Debate in High Gear

(2011) Cathy B. Moelans et al.   JNCI-Journal of the National Cancer Institute

Implications of rarity of chromosome 17 polysomy in breast cancer

(2011) Cathy B Moelans et al.   LANCET ONCOLOGY

Molecular subtyping of male breast cancer by immunohistochemistry

(2011) Robert Kornegoor et al.   MODERN PATHOLOGY

Gene expression analysis reveals a different transcriptomic landscape in female and male breast cancer

(2010) Maurizio Callari et al.   BREAST CANCER RESEARCH AND TREATMENT

High-resolution genomic profiling of male breast cancer reveals differences hidden behind the similarities with female breast cancer

(2010) Ida Johansson et al.   BREAST CANCER RESEARCH AND TREATMENT

Potential for Targeting the Fibroblast Growth Factor Receptors in Breast Cancer

(2010) N. E. Hynes et al.   CANCER RESEARCH

FGFR1 Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast Cancer

(2010) N. Turner et al.   CANCER RESEARCH

Chromosome 17 Polysomy without HER2 Amplification Does Not Predict Response to Lapatinib in Metastatic Breast Cancer--Letter

(2010) C. B. Moelans et al.   CLINICAL CANCER RESEARCH

Multidisciplinary Meeting on Male Breast Cancer: Summary and Research Recommendations

(2010) Larissa A. Korde et al.   JOURNAL OF CLINICAL ONCOLOGY

Molecular profiling of invasive breast cancer by multiplex ligation-dependent probe amplification-based copy number analysis of tumor suppressor and oncogenes

(2010) Cathy B Moelans et al.   MODERN PATHOLOGY

HER-2/neu amplification testing in breast cancer by Multiplex Ligation-dependent Probe Amplification: influence of manual- and laser microdissection

(2009) Cathy B Moelans et al.   BMC CANCER

Absence of chromosome 17 polysomy in breast cancer: analysis by CEP17 chromogenic in situ hybridization and multiplex ligation-dependent probe amplification

(2009) Cathy B. Moelans et al.   BREAST CANCER RESEARCH AND TREATMENT

MTDH Activation by 8q22 Genomic Gain Promotes Chemoresistance and Metastasis of Poor-Prognosis Breast Cancer

(2009) Guohong Hu et al.   CANCER CELL

Male Breast Cancer: A Population-Based Comparison With Female Breast Cancer

(2009) William F. Anderson et al.   JOURNAL OF CLINICAL ONCOLOGY

Does chromosome 17 centromere copy number predict polysomy in breast cancer? A fluorescencein situhybridization and microarray-based CGH analysis

(2009) Caterina Marchiò et al.   JOURNAL OF PATHOLOGY

Clinical validation of an array CGH test for HER2 status in breast cancer reveals that polysomy 17 is a rare event

(2009) I-Tien Yeh et al.   MODERN PATHOLOGY

Co-amplified genes at 8p12 and 11q13 in breast tumors cooperate with two major pathways in oncogenesis

(2009) S S Kwek et al.   ONCOGENE

The value ofTOP2Agene copy number variation as a biomarker in breast cancer: Update of DBCG trial 89D

(2008) Kirsten Vang Nielsen et al.   ACTA ONCOLOGICA

Prolactin and Estrogen Up-Regulate Carboxypeptidase-D to Promote Nitric Oxide Production and Survival of MCF-7 Breast Cancer Cells

(2008) Salma A. Abdelmagid et al.   ENDOCRINOLOGY

Genetic alterations of CCND1 and EMSY in breast cancers

(2008) T Kirkegaard et al.   HISTOPATHOLOGY

Conflicting evidence on the frequency of ESR1 amplification in breast cancer

(2008) Donna G Albertson   NATURE GENETICS